abstract：:Thyroid carcinoma on struma ovarii (TCSO) is a rare ovarian tumour, derivate from monodermic teratomas. It represents about 0.01% of overall ovarian tumours and 5 to 10% of struma ovarii. The diagnosis is histologic and retrospective after pelvic surgery; radiographic imaging being unspecific. Because of its rarity, t...

journal_title：Bulletin du cancer

authors： Lebreton C,Al Ghuzlan A,Floquet A,Kind M,Leboulleux S,Godbert Y

更新日期：2018-03-01 00:00:00

abstract：INTRODUCTION:Adapted physical activity (APA) is recognized as an effective supportive care for asthenia and quality of life in oncology. Before an APA program was organized, the feasibility of such a program was evaluated among the patients. METHODS:Descriptive, prospective, semi-qualitative, single-center study over ...

journal_title：Bulletin du cancer

authors： Crespel C,Brami C,de Boissieu P,Mazza C,Chauvet K,Lemoine A,Gavlak B,Léandri C,Brasseur M,Bertin E,Bouché O

更新日期：2018-03-01 00:00:00

abstract：:In order to help the clinician, mathematical models including several clinical and pathological variables are proposed in the literature with the aim to predict the occurrence of an event of interest. Nomograms allow individual prognosis for each patient. When they are developed, validated and correctly used, nomogram...

journal_title：Bulletin du cancer

authors： Filleron T,Chaltiel L,Jouve E,Cabarrou B,Gilhodes J,Lusque A,Mery E,Dalenc F,Martinez A

更新日期：2018-01-01 00:00:00

abstract：:Despite great improvements in the outcome of patients with lymphoma, some may still relapse or present with primary refractory disease. In these situations, allogeneic haematopoietic cell transplantation (allo-HCT) is a potentially curative option, in particular in the case of relapse after autologous stem cell transp...

journal_title：Bulletin du cancer

authors： Gauthier J,Chantepie S,Bouabdallah K,Jost E,Nguyen S,Gac AC,Damaj G,Duléry R,Michallet M,Delage J,Lewalle P,Morschhauser F,Salles G,Yakoub-Agha I,Cornillon J

更新日期：2017-12-01 00:00:00

abstract：:Despite great improvements in the outcome of patients with lymphoma, some may still relapse or present with primary refractory disease. In these situations, allogeneic hematopoietic cell transplantation is a potentially curative option, this is true particularly in the case of after autologous stem cell transplantatio...

journal_title：Bulletin du cancer

authors： Gauthier J,Chantepie S,Bouabdallah K,Jost E,Nguyen S,Gac AC,Damaj G,Duléry R,Michallet M,Delage J,Lewalle P,Morschhauser F,Salles G,Yakoub-Agha I,Cornillon J

更新日期：2017-12-01 00:00:00

abstract：:CAR T-cells are autologous or allogeneic human lymphocytes that are genetically engineered to express a chimeric antigen receptor targeting an antigen expressed on tumor cells such as CD19. CAR T-cells represent a new class of medicinal products, and belong to the broad category of Advanced Therapy Medicinal Products ...

journal_title：Bulletin du cancer

authors： Yakoub-Agha I,Ferrand C,Chalandon Y,Ballot C,Castilla Llorente C,Deschamps M,Gauthier J,Labalette M,Larghero J,Maheux C,Moreau AS,Varlet P,Pétillon MO,Pinturaud M,Rubio MT,Chabannon C

更新日期：2017-12-01 00:00:00

abstract：:Malnutrition is common in oncology. However, it is often detected too late and nutritional support is sub-optimal. The patient's opinion, although often sought in therapeutic decisions in oncology, does not appear to be frequently taken into account in dietetic management. In NutriCancer2012 study, we interviewed pati...

journal_title：Bulletin du cancer

authors： Raynard B,Hébuterne X,Goldwasser F,Ait Hssain A,Dubray Longeras P,Barthélémy P,Rosso E,Phoutthasang V,Bories C,Digue L,Laharie D,Desport JC,Falkowski S,Lacau Saint Guily J,Gyan E

更新日期：2017-11-01 00:00:00

abstract：:UPDATED 2016 RECOMMENDATIONS FOR THE CLINICAL PRACTICE OF NICE/SAINT-PAUL-DE-VENCE IN OVARIAN CANCER AND ADVANCED CERVICAL CANCER: Since the first edition of the 2012-2013 Clinical Practice Recommendations Nice-Saint-Paul for gynecological cancers, the management of ovarian cancer has become more complex with a better...

journal_title：Bulletin du cancer

authors： Joly F,Querleu D,Namer M,Pujade-Lauraine E

更新日期：2017-05-01 00:00:00

abstract：:Portal vein embolization consists of occluding a part of the portal venous system in order to achieve the hypertrophy of the non-embolized liver segments. This technique is used during the preoperative period of major liver resection when the future remnant liver (FRL) volume is insufficient, exposing to postoperative...

journal_title：Bulletin du cancer

authors： Piron L,Deshayes E,Escal L,Souche R,Herrero A,Pierredon-Foulongne MA,Assenat E,le Lam N,Quenet F,Guiu B

更新日期：2017-05-01 00:00:00

abstract：:Carcinomas are rare tumors of the adolescent-young adult (AYA) with a different spectrum from those of adults. The most common sites outside of the thyroid is the nasopharynx, salivary gland, colon-rectum and ovaries. If nasopharyngeal carcinoma or salivary gland tumors are good prognosis, others are more reserved pro...

journal_title：Bulletin du cancer

authors： Fresneau B,Dourthe ME,Jouin A,Laurence V,de Lambert G,Colas C,Coret M,Laprie A,Rebours C,Orbach D,Demoor-Goldschmidt C

更新日期：2017-03-01 00:00:00

abstract：INTRODUCTION:Genetic predisposition to familial hematological malignancies was previously described through several epidemiological analyses, but the genetic basis remains unclear. The tumor-suppressor ARLTS1 gene was previously described in sporadic hematological malignancies and familial cancer context. METHODS:In t...

journal_title：Bulletin du cancer

authors： Hamadou WS,Besbes S,Mani R,Bourdon V,Ben Youssef Y,Achour B,Regaieg H,Eisinger F,Mari V,Gesta P,Dreyfus H,Bonadona V,Dugast C,Zattara H,Faivre L,Noguchi T,Khélif A,Sobol H,Soua Z

更新日期：2017-02-01 00:00:00

abstract：:Urothelial tumors are very rare in children (to date, only about 150 cases have been reported worlwide). Only 20% occur before the age of ten. The aim of this study is to specify the clinicopathologic features of urothelial tumor in young patients, which require a slightly different approach to treatment. On the basis...

journal_title：Bulletin du cancer

authors： Grapin-Dagorno C,Peycelon M,Philippe-Chomette P,Berrebi D,El Ghoneimi A,Orbach D

更新日期：2017-02-01 00:00:00

abstract：:In an attempt to harmonize clinical practices among French hematopoietic stem cell transplantation centers, the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) held its sixth annual workshop series in September 2015 in Lille. This event brought together practitioners from across the c...

journal_title：Bulletin du cancer

authors： Dubois V,Brignier A,Elsermans V,Gagne K,Kennel A,Pedron B,Picard C,Ravinet A,Varlet P,Cesbron A,Delbos F,Yakoub-Agha I,Loiseau P

更新日期：2016-11-01 00:00:00

abstract：BACKGROUND:Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC). Due to its peculiar toxicities, improving patient's tolerance may need close follow-up. Nurses can play a crucial role, by driving a patient education program (EP). We aimed to prove that adding EP to usual care (UC) improves pa...

journal_title：Bulletin du cancer

authors： Brunot A,M'Sadek A,Le Roy F,Duval M,Le Sourd S,Ventroux E,Crouzet L,Guillygomarc'h A,Boucher E,Lelievre N,Laguerre B,Edeline J

更新日期：2016-11-01 00:00:00

abstract：:Haploidentical hematopoietic stem cell transplantation (HSCT) is being increasingly used due to improvement of the transplantation procedures allowing a reduction of graft-versus-host-disease (GVHD) and of transplant-related mortality (TRM). Such improvements have been particularly observed after administration of T-r...

journal_title：Bulletin du cancer

authors： Nguyen S,Chalandon Y,Lemarie C,Simon S,Masson D,Dhedin N,Suarez F,Renaud B,Charbonnier A,Yafour N,François S,Duléry R,Blaise D,Yakoub-Agha I,Rubio MT

更新日期：2016-11-01 00:00:00

abstract：:ANTI-PD-1 ANTIBODIES THERAPEUTIC USE IN LYMPHOID NEOPLASMS: Immune checkpoints blockade is under investigation in oncology, and has demonstrated its clinical efficacy. In hematology, immune checkpoints blockade is in earlier stages of development, but there are strong evidences of PD-1 blockade anti-tumor efficacy in ...

journal_title：Bulletin du cancer

authors： Bounaix L,Bendouda M,Bay JO,Lemal R

更新日期：2016-11-01 00:00:00

abstract：INTRODUCTION:Surgical treatment of malignant primitive tumors of bone needs a precise preoperative assessment of tumor local extension. Joint involvement (JI) represents the most important finding to determine, for the choice of surgical procedure (intra- or extra-articular resection). OBJECTIVE:To determine the value...

journal_title：Bulletin du cancer

authors： Chelli Bouaziz M,Riahi H,Mechri M,Abid L,Rafaa M,Ladeb MF

更新日期：2016-11-01 00:00:00

abstract：INTRODUCTION:An increasing number of patients with prostate cancer (PC) are diagnosed and treated. The aim of this study was to investigate urinary incontinence (UI) and sexual dysfunction (SD) two years after treatment for localized prostate cancer (PC). METHODS:This study followed all cases of localized PC diagnosed...

journal_title：Bulletin du cancer

authors： Bessaoud F,Orsini M,Iborra F,Rebillard X,Faix A,Soulier M,Daurès JP,Trétarre B

更新日期：2016-10-01 00:00:00

abstract：:Malnutrition is frequently observed in oncology. The consequences on patient survival, chemotherapy toxicities and quality of life need to be identified and treated appropriately. A set of tools are available that enable clinicians to diagnose and detect malnutrition. Each tool must consider three items: the patient's...

journal_title：Bulletin du cancer

authors： Khan S,Alibay TA,Merad M,DiPalma M,Raynard B,Antoun S

更新日期：2016-09-01 00:00:00

abstract：:Breast cancer remains a potentially lethal disease, which requires aggressive treatments and is associated with long-term consequences. Its prognosis is linked to both tumor biology and burden at diagnosis. Although treatments have allowed important improvements in prognosis over the past 20 years, breast cancer scree...

journal_title：Bulletin du cancer

authors： Delaloge S,Bachelot T,Bidard FC,Espie M,Brain E,Bonnefoi H,Gligorov J,Dalenc F,Hardy-Bessard AC,Azria D,Jacquin JP,Lemonnier J,Jacot W,Goncalves A,Coutant C,Ganem G,Petit T,Penault-Llorca F,Debled M,Campone M,Levy

更新日期：2016-09-01 00:00:00

abstract：UNLABELLED:The legislative process of the surrogate appears to be unclear to health professionals and to patients and next of kin. To better adapt this process to the clinical practice our objective was here to document how the persons designated as surrogate perceived their role and how they described the difficulties...

journal_title：Bulletin du cancer

authors： Sarradon-Eck A,Capodano G,Bureau E,Julian-Reynier C

更新日期：2016-07-01 00:00:00

abstract：:This review reports 3 of recently published molecular classifications of the 3 main gastro-intestinal cancers: gastric, pancreatic and colorectal adenocarcinoma. In colorectal adenocarcinoma, 6 independent classifications were combined to finally hold 4 molecular sub-groups, Consensus Molecular Subtypes (CMS 1-4), lin...

journal_title：Bulletin du cancer

authors： Dreyer C,Afchain P,Trouilloud I,André T

更新日期：2016-07-01 00:00:00

abstract：:The anticancer drug technical commission (COTECH) of the Auvergne OMEDIT has set up a region-wide professional practice evaluation (PPE) with regards to antiemetic prescription practices in chemotherapy-induced nausea and vomiting (CINV), in order to evaluate their compliance with OMEDIT's guidelines. Are not included...

journal_title：Bulletin du cancer

authors： Tavernier J,Jouannet-Romaszko M,Bertucat H,Marchiset N,Bahadoor M,Chevrier R

更新日期：2016-07-01 00:00:00

abstract：:During the last decade, inhibitors of the vascular endothelial growth factor (VEGF) were developed for the treatment of cancer. Many anti-VEGF are available but the issue is still the same: to inhibit the effect of the VEGF on their receptors. There are two main classes, depending on the mechanism of action by blockin...

journal_title：Bulletin du cancer

authors： Deray G,Janus N,Aloy B,Launay-Vacher V

更新日期：2016-07-01 00:00:00

abstract：:THE ROLE OF RUXOLITINIB IN THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS: The discovery of the JAK2V617F mutation in 2005, present in 95% of polycythemia vera (PV) and in 55% of myelofibrosis (MF) patients, opened the way for a new era of targeted therapies for myeloproliferative neoplasms. Ruxolitinib was the first-i...

journal_title：Bulletin du cancer

authors： Soret J,Kiladjian JJ

更新日期：2016-06-01 00:00:00

abstract：SURGICAL DE-ESCALATION FOR INVASIVE BREAST CANCER TREATMENT:A surgical therapeutic de-escalation is going to continue but necessarily has to design in a progressive careful way and especially arranged with the other practitioners and therapeutic methods. These strategies concern as well the surgery of the breast as tha...

journal_title：Bulletin du cancer

authors： Houvenaeghel G,Cohen M,Bannier M,Jauffret C,Buttarelli M,Lambaudie E

更新日期：2016-06-01 00:00:00

abstract：OBJECTIVE:The purpose of this study was to explore the risk factors that were associated with central lymph node metastasis (CLNM) in patients with clinical nodal negative differentiated thyroid carcinoma (cN0 DTC) after prophylactic central neck dissection (pCND). The influence of pCND on TNM staging and recurrence ri...

journal_title：Bulletin du cancer

authors： Lin X,Chen X,Jiru Y,Du J,Zhao G,Wu Z

更新日期：2016-06-01 00:00:00

abstract：OBJECTIVES:Radical prostatectomy (RP) remains a standard for localized prostate cancer treatment. The objective of this study is to present this operating technique of the robot-assisted radical prostatectomy (PR-RA) and to evaluate oncological and functional results as well as on the surgical safety. METHODS:A first ...

journal_title：Bulletin du cancer

authors： Hoepffner JL,Gaston R,Mugnier C,Rey D,Lopez L,Roche JB,Riviere J,Piechaud PT

更新日期：2016-05-01 00:00:00

abstract：:Angiogenesis inhibition is a major antitumor strategy that has emerged during the last decade. Oral tyrosine kinase inhibitors (TKI) targeting the VEGF receptor, including sunitinib, sorafenib, axitinib, regorafenib, pazopanib, and vandetanib reduce tumor growth and metastasis. These agents are approved for the treatm...

journal_title：Bulletin du cancer

authors： Bretagne M,Boudou-Rouquette P,Huillard O,Thomas-Schoemann A,Chahwakilian A,Orvoen G,Arrondeau J,Tlemsani C,Cessot A,Cabanes L,Blanchet B,Coriat R,Alexandre J,Goldwasser F

更新日期：2016-03-01 00:00:00

abstract：BACKGROUND:Depression is a sustainable state of deep sadness and abatement. It is frequently identified in patients with cancer and often undervalued by oncologists. The reduced PRIME-MD questionnaire is a questionnaire of 2 items validated in French. However, it has been neither translated nor validated in French. The...

journal_title：Bulletin du cancer

authors： Barriere J,Mari V,Cherikh F,Largillier R,Ettaiche M,Schiappa R,Chamorey E,Ferrero JM,Gal J

更新日期：2016-02-01 00:00:00

abstract：UNLABELLED:This CORCAN study is concerned with the way patients hospitalised for peritoneal carcinosis perceive surgical treatment and hyperthermic intraperitoneal chemotherapy (HIPEC). OBJECTIVES:(1) To identify and analyse, using concepts of social representation and accounts of the illness, characteristics of the w...

journal_title：Bulletin du cancer

authors： Durif-Bruckert C,Guilloux R,Guïoux A,Lasserre E,Goffette J,Régnier V

更新日期：2016-02-01 00:00:00

abstract：:Ten years after the discovery of the predictive value of KRAS status for anti-EGFR antibodies, other genes involved in oncogenesis and therapeutic responses were identified and are now systematically sought. Molecular diagnosis often requires invasive procedures, sometimes iatrogenic, and is limited by feasibility pro...

journal_title：Bulletin du cancer

authors： Pietrasz D,Pécuchet N,Fabre E,Blons H,Chevalier L,Taly V,Laurent-Puig P,Bachet JB

更新日期：2016-01-01 00:00:00

abstract：INTRODUCTION:French national guidelines lead us to increase the part of one-day breast cancer conservative surgery. Our objective was to check if we can enhance our outpatient part and to identify solutions to improve our practices. METHODS:From 01/01/2013 to 31/12/2014, we conducted a monocentric and retrospective re...

journal_title：Bulletin du cancer

authors： Gachon B,Nadeau C,Fritel X

更新日期：2015-12-01 00:00:00

abstract：INTRODUCTION:Adolescents and young adults (AYA, 15-25years old) with cancer are treated either in adult or pediatric units. Management of febrile neutropenia (FN) is different between these units. Monitoring rules and indications of hospitalization are often stricter in pediatrics. This study evaluates if these differe...

journal_title：Bulletin du cancer

authors： Penel-Page M,Normand C,Bertrand A,Levard A,Boyle H,Riberon C,Marec-Berard P

更新日期：2015-11-01 00:00:00

abstract：:Colorectal primary signet ring cell carcinoma (SRCC) is a rare entity accounting for nearly 1% of all colorectal carcinomas. It is an independent prognostic factor associated with less favorable outcome. This aggressiveness is mainly due to the intrinsic biology of these tumors. Here is an overview of the literature r...

journal_title：Bulletin du cancer

authors： Arifi S,Elmesbahi O,Amarti Riffi A

更新日期：2015-10-01 00:00:00

abstract：:According to the point 7.6 and 7.7 of the Cancer Plan 2014, all cancer patients should have access to supportive care. Indeed, the supportive care consultation in oncology is an important tool for the symptom management of cancer patients at all times of treatment. This consultation can be mono-disciplinary or multi-d...

journal_title：Bulletin du cancer

authors： Garnier SR,Pelletti C,Quenard C,Vallet F,Lemoine P,Guastella V,Rhondali W

更新日期：2015-09-01 00:00:00

abstract：:Alveolar soft part sarcoma, ASPS, is a rare malignant tumor, with preferential primary localization in limbs, usually occurring in adolescents and young adults. This sarcoma, well defined histologically and at molecular level, has an indolent course, but a high potential metastatic pulmonary and cerebral evolution, so...

journal_title：Bulletin du cancer

authors： Paillard C,Coulomb A,Helfre S,Orbach D

更新日期：2015-09-01 00:00:00

abstract：CONTEXT:Survival of children, adolescents and young adults treated for cancer increased with improved treatments. But there is still an increased risk of second primary cancer (SPC) in the long term compared to the population of the same age, especially related to treatments. A reflection on the follow-up of this popul...

journal_title：Bulletin du cancer

authors： Duval S,Carretier J,Boyle H,Philip T,Berger C,Marec-Bérard P,Fervers B

更新日期：2015-07-01 00:00:00

abstract：:Paclitaxel is conventionally used in a wide range of oncology indications. Nab-paclitaxel is synthesized by a process of high pressure homogenization of paclitaxel in the presence of human albumin and it was originally developed to reduce the toxicity usually associated with cremophor in soluble paclitaxel and to incr...

journal_title：Bulletin du cancer

authors： Lopez-Trabada Ataz D,Dumont S,André T

更新日期：2015-06-01 00:00:00

abstract：:Should we consider surgery for pancreatic cancer when resectability seems initially uncertain? The answer is no consensual as illustrated by the controversy presented here. This article presents the key arguments against surgery. ...

journal_title：Bulletin du cancer

authors： Évrard S

更新日期：2015-06-01 00:00:00